Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Staar Surgical CoSTAA +1.81%83 EV-to-EBITDA is 74.89 as of Jul. 23, 2026, which is 2% below its 10-year median of 76.09. GuruFocus rates STAA with a GF Score™ of 83/100 and a GF Value™ of $32.10 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 510 Medical Devices & Instruments companies, Staar Surgical Co ranks worse than 94.31% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Staar Surgical Co's enterprise value is $1,104.2 Mil.
Staar Surgical Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $14.7 Mil. Therefore, Staar Surgical Co's EV-to-EBITDA for today is 74.89.
The historical rank and industry rank for Staar Surgical Co's EV-to-EBITDA or its related term are showing as below:
STAA'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -2501.69 Med: 76.09 Max: 602.48
Current: 74.89
During the past 13 years, the highest EV-to-EBITDA of Staar Surgical Co was 602.48. The lowest was -2501.69. And the median was 76.09.
STAA's EV-to-EBITDA is ranked worse than 94.31% of 510
companies
in the Medical Devices & Instruments industry
Industry Median: 14.08
vs STAA: 74.89
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Staar Surgical Co (NAS:STAA) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Staar Surgical Co's PE Ratio (TTM) for today is calculated as:
Staar Surgical Co's share price for today is $24.72.
Staar Surgical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.430.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Staar Surgical Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Staar Surgical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Staar Surgical Co EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Staar Surgical Co's EV-to-EBITDA falls into.
Staar Surgical Co's current Enterprise Value is $1,104.2 Mil.
Staar Surgical Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Staar Surgical Co (STAA) has a EV-to-EBITDA of 74.89 as of Jul. 23, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Staar Surgical Co. This is near median its historical median of 76.09. According to the industry distribution chart, Staar Surgical Co ranks #481 out of 510 companies in the Medical Devices & Instruments industry, placing it in the top 94.3%.
Is Staar Surgical Co's EV-to-EBITDA too high?
Staar Surgical Co's current EV-to-EBITDA of 74.89 is near median its 10-year median of 76.09. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.08. Staar Surgical Co's value of 74.89 is 431.9% above this industry median. Based on the distribution chart, Staar Surgical Co ranks #481 out of 510 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Staar Surgical Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's EV-to-EBITDA compare to BLFS and ATRC?
According to the Medical Devices & Instruments industry distribution chart, Staar Surgical Co ranks #481 out of 510 companies for EV-to-EBITDA. This places Staar Surgical Co in the lower half of its industry. The industry median EV-to-EBITDA is 14.08. Staar Surgical Co's value of 74.89 is 431.9% above this benchmark. While the company's 10-year median is 76.09 vs. the industry median of 14.08, Staar Surgical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.08, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Staar Surgical Co's current EV-to-EBITDA of 74.89 is 431.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Staar Surgical Co. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Staar Surgical Co's current EV-to-EBITDA is 74.89, which is near median its own 10-year median of 76.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STAA) is currently considered Modestly Undervalued. The stock's GF Value™ is $32.10, compared to a current price of $24.72 — trading 23% below its estimated fair value. The current EV-to-EBITDA is 74.89, which is near median its 10-year median of 76.09 and 431.9% above the Medical Devices & Instruments industry median of 14.08. Staar Surgical Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Staar Surgical Co (STAA), the current EV-to-EBITDA is 74.89 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Staar Surgical Co (STAA) Overvalued in 2026?
Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued.
The current stock price of $24.72 is trading 23% below its estimated GF Value™ of $32.10.
GuruFocus considers Staar Surgical Co to be Modestly Undervalued.
Key valuation signals for STAA:
EV-to-EBITDA: 74.89 (near median its 10-year median of 76.09)
GF Value™: $32.10 vs. price of $24.72 (23% below fair value)
Industry Position: 431.9% above the Medical Devices & Instruments median (#481 of 510)
No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
83GF Score
Get the complete analysis for STAA
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STAA has been successfully added to your 
